Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

EUPANTOL® 40 mg IV: 1er IPP injectable remboursable en médecine de ville

    • 28 Accesses

    This is a preview of subscription content, log in to check access.

    About this article

    Cite this article

    EUPANTOL® 40 mg IV: 1er IPP injectable remboursable en médecine de ville. Acta Endosc 36, 380 (2006). https://doi.org/10.1007/BF03006060

    Download citation